Measurement of S-100 Protein Using the Automated Chemiluminescence System Lia-Mat 300

Henze G Dummer R Jemelka Hi Joller Böni R Burg G. Serum S100 — a marker for disease monitoring in metastatic melanoma. Dermatology 1997; 194: 208–12.

Buer J Probst M Franzke A Duensing S Haindl J Volkenandt M Elevated serum levels of S100 and survival in metastatic malignant melanoma. Br J Canter 1997; 75: 1373–6.

Seregni E Massaron S Martinetti A Illeni MT Rovini D Belli F S100 protein serum in cutaneous malignant malanoma. Oncol Rep 1998; 5: 601–4.

Guo HB Stoffel-Wagner B Bierwirth T Mezger J Klingmüller D. Clinical significance of serum S-100 in metastatic malignant melanoma. Eur J Cancer 1995; 31A: 924–8.

Abraha HD Fuller LC Du Vivier AWP Higgins EM Sherwood RA. Serum S100 — a potentially useful prognostic marker in cutaneous melanoma. Br J Dermatol 1997; 137: 381–5.

Von Schoultz E Hansson LO Diureen E Hansson J Kärnell R Nilsson B Prognostic value of serum analyses of S-100β protein in malignant melanoma. Melanoma Res. 1996; 6: 133–7.